申请人:WARNER-LAMBERT COMPANY
公开号:EP1233016A1
公开(公告)日:2002-08-21
Inhibitors of MMP enzymes are cyclic sulfonamides of Formula I
or a pharmaceutically acceptable salt thereof, and cyclic sulfonamides of Formula III
or a pharmaceutically acceptable salt thereof,
wherein R1 and R2 include hydrogen, alkyl, and substituted alkyl; R3 and R4 include hydrogen, halo, and alkyl; X is OH or NHOH. The compounds of Formulas I and III are useful for the treatment of diseases mediated by an MMP enzyme, including cancer, osteoarthritis, rheumatoid arthritis, heart failure, and inflammation.
MMP酶抑制剂是公式I的环状磺酰胺或其药学上可接受的盐和公式III的环状磺酰胺或其药学上可接受的盐,其中R1和R2包括氢、烷基和取代烷基;R3和R4包括氢、卤素和烷基;X为OH或NHOH。公式I和III的化合物对于治疗由MMP酶介导的疾病非常有用,包括癌症、骨关节炎、类风湿性关节炎、心力衰竭和炎症。